Improved Drug Patent Coordination: Agency Collaboration for Innovation.
This new law enhances cooperation between the Patent Office and the Food and Drug Administration. The goal is to process drug patent applications more quickly and accurately, potentially accelerating access to new therapies and ensuring their safety. Citizens may benefit from faster market introduction of innovative medicines.
Key points
A special task force is established, bringing together patent and drug experts to share information.
Agencies will share data on new drugs, technologies, and scientific trends to improve patent decision-making.
Rules for protecting confidential company information are introduced to ensure data security during inter-agency exchange.
Placed on Calendar
Citizen Poll